Matches in Nanopublications for { ?s ?p "[ This weekly irinotecan/docetaxel regimen has shown an acceptable toxicity profile while encouraging median and 1-year survival in heavily pretreated NSCLC patients. The tendency to better prognosis in patients carrying the variant genotypes 6/7 and 7/7 o]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP80650.RA0q7hRswg_IoO8l8qRQXkzDGY4XMMDvUcQTziSLvcHW8130_assertion description "[ This weekly irinotecan/docetaxel regimen has shown an acceptable toxicity profile while encouraging median and 1-year survival in heavily pretreated NSCLC patients. The tendency to better prognosis in patients carrying the variant genotypes 6/7 and 7/7 o]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP80650.RA0q7hRswg_IoO8l8qRQXkzDGY4XMMDvUcQTziSLvcHW8130_provenance.
- NP82351.RAJuxwWbMSQBR7MO6Qo14o9wAEk87Y_nLIU-5kK01bxc0130_assertion description "[ This weekly irinotecan/docetaxel regimen has shown an acceptable toxicity profile while encouraging median and 1-year survival in heavily pretreated NSCLC patients. The tendency to better prognosis in patients carrying the variant genotypes 6/7 and 7/7 o]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP82351.RAJuxwWbMSQBR7MO6Qo14o9wAEk87Y_nLIU-5kK01bxc0130_provenance.